1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Skye Bioscience, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo Nimacimab injection, Nimacimab placebo injection, semaglutide injection - Obesity | Phase 2 | Active not recruiting | Skye Bioscience, Inc. | 136 | 2024-08-22 | 2026-01-14 |
| Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure SBI-100 Ophthalmic Emulsion, 0.5%, SBI-100 Ophthalmic Emulsion, 1.0%, SBI-100 Ophthalmic Emulsion, Placebo - Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | Skye Bioscience, Inc. | 56 | 2023-11-09 | 2026-01-14 |
Glaucoma (1) · Glaucoma, Open-Angle (1) · Obesity (1) · Ocular Hypertension (1)
Injections (1) · semaglutide (1)
United States (2)
Tu Diep (1)